MACS® Catalyst™: Tailored Support From Concept To Commercialization

The MACS Catalyst Program offers a strategic pathway for innovators in cell and gene therapy to accelerate their progress from research to commercialization. Designed for academic teams, biotech startups, and pharmaceutical developers, the program provides access to Miltenyi Biotec’s advanced CGT technologies and infrastructure. Participants benefit from GMP-grade reagents, automated cell processing platforms, and scalable manufacturing solutions—all supported by a global network of CGT experts. Whether you're optimizing preclinical workflows or preparing for clinical-scale production, the program is built to meet the rigorous demands of regulatory and clinical environments. It’s more than a technology offering—it’s a partnership designed to help you move faster and smarter.

Explore how this program can support your next milestone in CGT development.